Filing Details
- Accession Number:
- 0001209191-23-002543
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-09 16:05:16
- Reporting Period:
- 2023-01-05
- Accepted Time:
- 2023-01-09 16:05:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1446847 | Ironwood Pharmaceuticals Inc | IRWD | Pharmaceutical Preparations (2834) | 043404176 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1478448 | A Thomas Mccourt | C/O Ironwood Pharmaceuticals, Inc. 100 Summer Street, Suite 2300 Boston MA 02110 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2023-01-05 | 110,962 | $11.65 | 823,402 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2023-01-05 | 110,962 | $12.07 | 712,440 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Employee Stock Options (Right to Buy) | Disposition | 2023-01-05 | 110,962 | $0.00 | 110,962 | $11.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-02-01 | No | 4 | M | Direct |
Footnotes
- The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.01 to $12.29, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The options, vested as to 1.25% on each monthly anniversary of the vesting commencement date for the first 36 months, and as to 4.5833% of the award on each monthly anniversary thereafter, are presently exercisable in full.
Billionaire Hedge Funds
